MyFinsight
Home
About
Contact
ntla: the income statement
Download
Download image
Comprehensive loss
-$100,987K
(23.06%↑ Y/Y)
Unrealized gain on
marketable securities
$337K
(-92.43%↓ Y/Y)
Change in fair value of
investments, net
$3,439K
(212.24%↑ Y/Y)
Interest income
$6,714K
(-44.61%↓ Y/Y)
Net loss
-$101,324K
(25.34%↑ Y/Y)
Total other income,
net
$10,153K
(12.09%↑ Y/Y)
Operating loss
-$111,477K
(23.00%↑ Y/Y)
Collaboration revenue
$13,782K
(51.27%↑ Y/Y)
Total operating
expenses
$125,259K
(-18.60%↓ Y/Y)
General and
administrative
$30,512K
(0.04%↑ Y/Y)
Research and development
$94,747K
(-23.21%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Intellia Therapeutics, Inc. (NTLA)
Intellia Therapeutics, Inc. (NTLA)